Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Gemcitabine Plus High-Dose Ascorbate in Locally Advanced Unresectable or Metastatic Soft Tissue and Bone Sarcomas in Adults

NCT04634227 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT04634227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04634227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Gemcitabine Plus High-Dose Ascorbate in Locally Advanced Unresectable or Metastatic Soft Tissue and Bone Sarcomas in Adults
Lead sponsor
University of Iowa
Phase
Phase 1
Overall status
Active, not recruiting
Start date
November 24, 2020
Completion date
December 31, 2026
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone sarcoma, metastatic bone tumor, sarcoma, soft tissue sarcoma, unresectable soft tissue sarcoma